Creyon Bio, Inc. is a pioneering drug development company based in San Diego, CA, that is revolutionizing the field with its innovative approach to creating oligonucleotide-based medicines. By leveraging powerful data sets and machine learning models, Creyon Bio engineers safe and precise gene-centric therapies with unprecedented speed and predictable efficacy and safety, ultimately making on-demand oligonucleotide therapeutics a reality. Their groundbreaking modular approach significantly reduces costs for developing new medicines, whether for individual patients or large populations.
With a multidisciplinary team of chemists, biologists, and computational scientists, Creyon Bio dares to color outside the lines in tackling the challenges of drug development. Through collaborations with industry partners, patient advocates, and policymakers, they are committed to delivering gene-centric medicines in a timely and cost-effective manner to those who need them most. As a leader in the field, Creyon Bio is featured in prestigious reports and research projects, highlighting their dedication to disrupting and transforming the pharmaceutical and biotech industry.
Generated from the website